Skip to main content
Equibles
BDSX logo

BDSX · Biodesix Inc

Track BDSX — free

Use BDSX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$26.18 -0.30 (-1.11%) At close · Sep 4
Rebalance outlook locked
Market Cap
$276.23M
Shares
10.55M

BDSX metrics

65 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$26.18
Market cap
$276.23M

Price action

19 metrics
Price change (1W)
-2.4%
Price change (30D)
+11.4%
Price change (3M)
+69.3%
Price change (6M)
+39.4%
Price change (YTD)
+285.0%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
111.4%
Beta
1.1
RSI (14D)
53.8
Price vs SMA 50
+12.3%
Price vs SMA 200
+74.9%
Avg volume (3M)
97,118
Relative volume
0.6
Average dollar volume
$2.22M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
10.55M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.9×
reciprocal yield 34.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
2.7×
reciprocal yield 37.3%
P / book
30.2
reciprocal yield 3.3%
FCF yield
-7.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-10.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.4×
reciprocal yield 41.6%
EV / revenue historical average (5Y)
2.4×
reciprocal yield 40.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
-20.0%
Trailing 12 months
Net margin
-27.0%
Gross profit (TTM)
—
Operating profit (TTM)
−$20.61M
Net income (TTM)
−$27.76M
Trailing 12 months
Diluted EPS (TTM)
$-3.11
FCF margin
-19.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-17,663.64

Growth

11 metrics
Revenue growth YoY
+34.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$102.94M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+40.4%
Year over year · more shares
Revenue CAGR (3Y)
+32.3%
Revenue CAGR (5Y)
+14.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-303.6%
Return on assets
-29.1%
Debt / equity
5.5
Current ratio
2.8
EBITDA (TTM)
−$15.03M
Free cash flow (TTM)
−$20.24M
Quick ratio
2.8
Interest coverage
-2.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$20.00M
Latest balance sheet
Cash & equivalents
$30.00M
Total assets
$95.33M
Total debt
$50.00M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$19.83M
Capital expenditures (TTM)
$412,000
R&D (TTM)
$12.28M
SG&A (TTM)
$93.23M
Stock compensation (TTM)
$4.06M
R&D / revenue
11.9%
Stock compensation / revenue
3.9%

Ownership (13F)

3 metrics
13F filers
44
13F filer change QoQ
+3
Institutional ownership
40.6%

Short interest

3 metrics
Short interest
1.4%
Latest settlement · 1.6 days to cover
Days to cover
1.6d
Short-squeeze score
48 / 100

Insider activity

2 metrics
Net insider buying (90D)
$1.03M
Insider-sentiment score
88 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1439725 CUSIP 09075X207 13F (30d) 35 filings 35 filers Visit website Investor relations